
Biocytogen Announces FDA Clearance of IND Application for Bispecific Antibody YH008
BEIJING–(BUSINESS WIRE)–#CD40–Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) today announced that the US FDA has approved the Investigational New Drug (IND) application for a […]














